Skift Take
Japan is clearly taking steps to get ready for a reopening to foreign tourists– not simply the gradual border easing that will happen next month. But the country’s rejection to consist of vaccines established by Chinese makers is an indication Japan isn’t anticipating visitors from China anytime quickly.
Rashaad Jorden
Japan stated on Thursday worldwide visitors revealing proof of a Covid-19 vaccination with the Johnson & Johnson shot would be allowed in and be qualified for a shorter time in quarantine when border controls are eased next month.
The J&J shot, which has not been authorized in Japan, will join a list of three other shots that have been authorized by regulators as sufficient for non-residents to go into, after a nearly two-year ban on such tourists.
The other approved vaccines on a list that the foreign ministry launched on Thursday are the ones established by Pfizer Inc, Moderna Inc, and Astrazeneca Plc.
. Vaccines developed by Chinese and Russian makers are not included.
From March 1, authorities will raise the variety of people allowed to Japan to 5,000 a day, from 3,500, Prime Minister Fumio Kishida informed reporters recently. The alleviating applies to students, employees, and other visa holders, however not to travelers for the time being.
The quarantine duration will be lowered to 3 days in some conditions, from seven, and it will be waived entirely depending on the tourist’s point of origin, and if they have had a booster shot.
(Reporting by Rocky Swift Modifying by Robert Birsel)
This post was from Reuters and was legally licensed through the Industry Dive Material Market. Please direct all licensing concerns to [e-mail secured]